As Arizona continues its decline in COVID-19 cases and hospitalizations, schools and universities are planning how they will reopen as new metrics are set to be released today to guide the return of students to the classroom. Researchers and hospitals are leading dozens of clinical trials in Arizona with the hope of finding better drugs to treat COVID-19, which has now claimed more than 4,000 lives in Arizona.
Health officials: Influx of UA students could cause spike in Tucson’s COVID-19 cases / Arizona Daily Star
NAU supporting businesses, communities during COVID-19 / Flagstaff Business News (Op-ed)
‘Amazing, isn’t it?’ Long-sought blood test for Alzheimer’s in reach / New York Times
Banner Alzheimer’s Institute played a lead role in an international study of a new blood test that may speed research for treatments and provide a diagnosis for dementia patients who want to know if they have Alzheimer’s disease.
The Advanced Heart Failure Center at Banner—University Medical Center Phoenix conducted its first transplant in February and has completed 10 heart transplants as of January.
A University of Arizona scientist has earned $3.8 million in federal funding from the National Institute on Aging to further research on medications to help prevent or reverse the progression of Alzheimer’s disease. Read more: UA scientists investigate connection between Alzheimer’s and Down syndrome
New Pima Community College scholarship to diversify STEM fields / KGUN
A $4.8 million grant funded by the National Science Foundation will provide scholarships to 94 eligible students who are pursuing associate degrees at Pima Community College with the intention of transferring and completing Bachelor of Science degrees at the University of Arizona.